DK0981377T3 - Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling - Google Patents

Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling

Info

Publication number
DK0981377T3
DK0981377T3 DK98914877T DK98914877T DK0981377T3 DK 0981377 T3 DK0981377 T3 DK 0981377T3 DK 98914877 T DK98914877 T DK 98914877T DK 98914877 T DK98914877 T DK 98914877T DK 0981377 T3 DK0981377 T3 DK 0981377T3
Authority
DK
Denmark
Prior art keywords
complexes
preparation
methods
polyamino acids
lhrh antagonist
Prior art date
Application number
DK98914877T
Other languages
Danish (da)
English (en)
Inventor
Thomas Reissmann
Juergen Engel
Wolfgang Deger
Guenter Losse
Wolfgang Naumann
Sandra Murgas
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of DK0981377T3 publication Critical patent/DK0981377T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98914877T 1997-03-26 1998-03-11 Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling DK0981377T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712718A DE19712718C2 (de) 1997-03-26 1997-03-26 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
PCT/EP1998/001398 WO1998042381A1 (de) 1997-03-26 1998-03-11 Immobilisierte und aktivitätsstabilisierte komplexe von lhrh-antagonisten und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0981377T3 true DK0981377T3 (da) 2003-11-10

Family

ID=7824698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98914877T DK0981377T3 (da) 1997-03-26 1998-03-11 Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling

Country Status (27)

Country Link
US (2) US6022860A (ru)
EP (1) EP0981377B1 (ru)
JP (1) JP4180120B2 (ru)
CN (1) CN1150943C (ru)
AR (1) AR012186A1 (ru)
AT (1) ATE249245T1 (ru)
AU (1) AU747808B2 (ru)
BR (1) BR9807887B1 (ru)
CA (1) CA2285054C (ru)
CZ (1) CZ300755B6 (ru)
DE (2) DE19712718C2 (ru)
DK (1) DK0981377T3 (ru)
ES (1) ES2206912T3 (ru)
HK (1) HK1025255A1 (ru)
HU (1) HUP0002059A3 (ru)
IL (1) IL131181A (ru)
NO (1) NO327404B1 (ru)
NZ (1) NZ337343A (ru)
PL (1) PL190090B1 (ru)
PT (1) PT981377E (ru)
RU (1) RU2207151C2 (ru)
SK (1) SK284461B6 (ru)
TR (1) TR199902168T2 (ru)
TW (1) TW520288B (ru)
UA (1) UA69381C2 (ru)
WO (1) WO1998042381A1 (ru)
ZA (1) ZA982225B (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE69912422T2 (de) * 1998-04-23 2004-08-19 Zentaris Gmbh Methode zur behandlung von fruchtbarkeitsstörungen
CO5160256A1 (es) * 1999-02-08 2002-05-30 Zentaris Ag Sales de peptidos farmaceuticamente activos para la liberacion sostenida y proceso de produccion
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US7037889B2 (en) 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
PE20020908A1 (es) * 2001-03-21 2002-10-26 Cell Therapeutics Inc Produccion recombinante de polimeros polianionicos y uso de de los mismos
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
JP5369336B2 (ja) 2007-01-02 2013-12-18 アクアビーム エルエルシー 前立腺の疾患を治療するための侵襲性が最小である方法及びデバイス
US8814921B2 (en) * 2008-03-06 2014-08-26 Aquabeam Llc Tissue ablation and cautery with optical energy carried in fluid stream
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
US8853354B2 (en) 2009-03-27 2014-10-07 Kagoshima University Polyion complex comprising hydrophobized polyamino acid and use of the same
WO2016004071A1 (en) 2014-06-30 2016-01-07 Procept Biorobotics Corporation Fluid jet tissue resection and cold coagulation (aquablation) methods and apparatus
CN104203078B (zh) 2012-02-29 2018-04-20 普罗赛普特生物机器人公司 自动化图像引导的组织切除和处理
CN105431096B (zh) 2013-02-14 2018-07-31 普罗赛普特生物机器人公司 液体消融液体束眼外科手术的方法和装置
BR112016005036A2 (pt) 2013-09-06 2020-04-07 Procept Biorobotics Corp aparelho para ressecção de tecido guiada por imagem automatizada
CN107072591B (zh) 2014-09-05 2021-10-26 普罗赛普特生物机器人公司 与靶器官图像的治疗映射结合的医师控制的组织切除

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE257197C (ru) *
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
DD257197A1 (de) * 1987-01-28 1988-06-08 Univ Dresden Tech Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
DD269785A1 (de) * 1988-02-08 1989-07-12 Univ Dresden Tech Verfahren zur herstellung von aktivitaetsstabilisierten und in ihren pharmakologischen eigenschaften modifizierten peptidderivaten
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
ATE131042T1 (de) * 1990-04-25 1995-12-15 Hoechst Ag Pharmakologische zubereitung, enthaltend polyelektrolytkomplexe in mikropartikulärer form und mindestens einen wirkstoff.
DD299265A5 (de) * 1990-09-11 1992-04-09 Technische Universitaet Dresden,De Verfahren zur herstellung von immobilisierten und aktivitaetsstabilisierten praeparaten des gonadotropin-releasing-hormons oder dessen analoga mit polyaminosaeuren
US5834520A (en) * 1992-10-08 1998-11-10 Asta-Medica Aktiengesellschaft Container for injectable mesna solutions
WO1994011015A1 (en) * 1992-11-12 1994-05-26 Molecular Dynamics, Inc. Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5449720A (en) * 1993-05-24 1995-09-12 Biotech Australia Pty Limited Amplification of the VB12 uptake system using polymers
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides

Also Published As

Publication number Publication date
DE59809575D1 (de) 2003-10-16
TW520288B (en) 2003-02-11
BR9807887A (pt) 2000-02-22
WO1998042381A1 (de) 1998-10-01
CA2285054C (en) 2007-08-21
US6054555A (en) 2000-04-25
HK1025255A1 (en) 2000-11-10
NO994665D0 (no) 1999-09-24
RU2207151C2 (ru) 2003-06-27
ES2206912T3 (es) 2004-05-16
HUP0002059A3 (en) 2001-02-28
PL190090B1 (pl) 2005-10-31
IL131181A0 (en) 2001-01-28
SK284461B6 (sk) 2005-04-01
TR199902168T2 (xx) 1999-12-21
CZ337199A3 (cs) 2000-03-15
CZ300755B6 (cs) 2009-08-05
PT981377E (pt) 2004-02-27
EP0981377A1 (de) 2000-03-01
SK131699A3 (en) 2000-05-16
ATE249245T1 (de) 2003-09-15
EP0981377B1 (de) 2003-09-10
AU6920798A (en) 1998-10-20
AU747808B2 (en) 2002-05-23
AR012186A1 (es) 2000-09-27
JP2001520662A (ja) 2001-10-30
ZA982225B (en) 1998-04-03
DE19712718C2 (de) 1999-09-23
CN1249691A (zh) 2000-04-05
NO327404B1 (no) 2009-06-22
CA2285054A1 (en) 1998-10-01
NO994665L (no) 1999-09-24
IL131181A (en) 2004-09-27
PL335830A1 (en) 2000-05-22
BR9807887B1 (pt) 2010-05-18
US6022860A (en) 2000-02-08
JP4180120B2 (ja) 2008-11-12
HUP0002059A2 (hu) 2000-10-28
DE19712718A1 (de) 1998-10-01
NZ337343A (en) 2001-10-26
CN1150943C (zh) 2004-05-26
UA69381C2 (ru) 2004-09-15

Similar Documents

Publication Publication Date Title
DK0981377T3 (da) Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling
IS2321B (is) Aðferðir og blöndur til að fyrirbyggja þol gegn berkjuvíkkandi lyfjum
DK0927192T3 (da) Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
DE69704712T2 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
FI103614B1 (fi) Vaiheistus- ja balansointielin
IS6183A (is) Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO984082D0 (no) Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremstilling derav
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20001554L (no) FremgangsmÕter og mellomprodukter nyttige for Õ fremstille antifolater
DK1114641T3 (da) Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DK0931081T3 (da) Pyridazino-[4,5-B]-quinolin-5-oxid-derivater, deres fremstilling og deres anvendelse som glycinantagonister
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
DE69802131D1 (de) Humane Protein-Kinase hYAK3
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
NO20003606L (no) Triazepinoner, fremgangsmÕte for deres fremstilling, samt deres terapeutiske anvendelse
DK0917827T3 (da) Fremgangsmåde til fremstilling af flæsk og den særlige anvendelse af det ifølge denne fremgangsmåde fremstillede flæsk